1492 Capital Management’s CAS Medical Systems, Inc. CASM Stock Holding History

1492 Capital Management’s Portfolio CASM Stock Details CASM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-42,346	Closed	-$39K	–	111
2017 Q3	$39K	Sell	42,346 -6,986	-14%	-$7.16K	0.03%	92
2017 Q2	$57K	Sell	49,332 -698	-1%	-$798	0.05%	99
2017 Q1	$73K	Buy	50,030 +1,629	+3%	+$2.48K	0.06%	101
2016 Q4	$78K	Sell	48,401 -21,865	-31%	-$36.7K	0.06%	103
2016 Q3	$121K	Sell	70,266 -1,678	-2%	-$2.91K	0.1%	100
2016 Q2	$132K	Sell	71,944 -865	-1%	-$1.62K	0.12%	101
2016 Q1	$103K	Hold	72,809	–	–	0.09%	103
2015 Q4	$129K	Sell	72,809 -119	-0.2%	-$168	0.09%	110
2015 Q3	$91K	Sell	72,928 -441,806	-86%	-$523K	0.06%	112
2015 Q2	$659K	Sell	514,734 -195,035	-27%	-$253K	0.42%	64
2015 Q1	$948K	Buy	709,769 +38,989	+6%	+$56.2K	0.55%	49
2014 Q4	$1.11M	Sell	670,780 -24,479	-4%	-$43.3K	0.69%	39
2014 Q3	$1.35M	Buy	695,259 +8,851	+1%	+$15.3K	0.75%	33
2014 Q2	$1.38M	Buy	686,408 +54,523	+9%	+$115K	0.71%	37
2014 Q1	$1.37M	Buy	631,885 +85,510	+16%	+$182K	0.68%	40
2013 Q4	$929K	Buy	+546,375	New	+$853K	0.5%	50

Other funds holding CASM

ACP

Acuta Capital Partners Redwood City, California $142M AUM 783.79% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return

TCM

TD Capital Management Memphis, Tennessee $1.11B AUM 10.06% 1-Year Est. Return

Penbrook Management New York $132M AUM 29.91% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

TSS

Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return

CRC

Curi RMB Capital Chicago, Illinois $5.62B AUM 18.93% 1-Year Est. Return

1492 Capital Management's CASM Position: Q4 2017 in Review

1492 Capital Management sold out of CAS Medical Systems, Inc. (CASM) in Q4 2017, closing a stake of 42,346 shares — an estimated $39K sold.

1492 Capital Management first reported a position in CASM in Q4 2013 and held it in 16 quarters. The position peaked at $1.38M in Q2 2014. 19 funds tracked by Wall St. Rank hold CASM as of Q4 2017.

1492 Capital Management reported no remaining CAS Medical Systems, Inc. position as of Q4 2017 after selling out during the quarter.
1492 Capital Management sold 42,346 CAS Medical Systems, Inc. shares in Q4 2017, an estimated $39K.
1492 Capital Management first reported a position in CAS Medical Systems, Inc. in Q4 2013 and held it in 16 quarters.
1492 Capital Management's CAS Medical Systems, Inc. position peaked at $1.38M in Q2 2014.
19 funds tracked by Wall St. Rank held CAS Medical Systems, Inc. as of Q4 2017.

Based on 1492 Capital Management's 13F filing for Q4 2017, filed 14 Feb 2018.